Content about Fungal diseases

January 31, 2013
Monistat survey: 75% of women experience yeast infections, but misconceptions persist

Research has shown that 3-in-4 women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced, citing an independent survey commissioned for Monistat.

TREVOSE, Pa. — Research has shown that three in four women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced Wednesday, citing an independent survey commissioned for Monistat.

July 27, 2012
Mylan launches antifungal drug

Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

PITTSBURGH — Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

Mylan announced the launch of itraconazole capsules in the 100-mg strength. The drug is a generic version of Johnson & Johnson's Sporanox, which is used to treat fungal infections that begin in the lungs blatsomycosis, histoplasmosis and aspergillosis in patients who are intolerant of or refractory to amphotericin B therapy. The drug also is used to treat fungal infections in the toenails and fingernails in patients without compromised immune systems.

May 31, 2012
Mexican athlete's foot brand making its way across the border to U.S. Hispanic markets

MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

EL SEGUNDO, Calif. — MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

The brand is expanding its U.S. distribution and can be found at such retailers as Walmart and Target in key U.S. Hispanic markets, such as Los Angeles, Houston, Dallas and Chicago, the company said.

May 23, 2012
FDA approves treatment for vaginal fungus infections

The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

Perrigo announced the approval of butoconazole nitrate 2% vaginal cream, a generic version of KV Pharmaceutical's Gynazole-1, used to treat vulvovaginal candidiasis, an infection caused by Candida fungus. KV voluntarily discontinued selling the drug in January 2009 due to manufacturing problems.

March 21, 2011
Hi-Tech Pharmacal acquires candidiasis treatment

Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.

The market for the drug is $23 million, according to IMS Health.

March 8, 2011
3M debuts Cavilon antifungal cream

3M's skin and wound care division has launched an easy-to-apply cream that is designed to relieve skin discomforts caused by fungal infections.

ST. PAUL, Minn. — 3M's skin and wound care division has launched an easy-to-apply cream that is designed to relieve skin discomforts caused by fungal infections.

New Cavilon antifungal cream, which is available in 2-oz. and 5-oz. tubes, is enriched with water-repelling ingredients, including 2% miconazole nitrate, an active ingredient that has been clinically proven to treat tinea corporis (ringworm), tinea pedis (athlete’s foot) and tinea cruris (jock itch), 3M said. The product also is approved for use on fungal infections caused by Candida albicans.

August 19, 2010
Study finds anti-inflammatory drug may help fight fungal infection of the lungs

An anti-inflammatory drug approved 60 years ago may help fight against a fungal infection of...

June 9, 2010
FDA approves generic Lamisil from Breckenridge

The Food and Drug Administration has approved Breckenridge Pharmaceutical’s generic version of a fungal infection...